U.S. Logistics Stock News

Leidos Holdings (LDOS) has been added to both the Russell 1000 Value Defensive Index and the Russell 1000 Defensive Index, drawing renewed focus to how the stock aligns with investors seeking resilient exposure. See our latest analysis for Leidos Holdings. Despite Leidos Holdings securing new index placements and AI focused partnerships, recent momentum has been weak, with the 30 day share price return down 19.3% and the year to date share price return down 43.82%, even as the 3 year total...

In late June 2026, Upwork Inc. was added to several Russell value benchmarks, including the Russell 2000, 2500, 3000, 3000E, and Small Cap Composite Value Indexes, while also securing a new US$150.0 million revolving credit facility maturing in 2029. This combination of expanded index inclusion and enhanced financial flexibility could influence how investors view Upwork’s position in the freelance work marketplace and its capacity to fund future initiatives. We’ll now explore how Upwork’s...

agilon health stock has delivered a very large year to date gain, yet the current valuation checks still lean cheap. This sets up a clear question of whether the recent enthusiasm has run ahead of fundamentals or if the market is only starting to reprice the business. Year to date, agilon health is up a very large 563.5%, which puts extra focus on whether the current price leaves enough room for mistakes. Recent analyst upgrades tied to an improved outlook for value based care and margin...

In late June 2026, Toast, Inc. (NYSE: TOST) was added to the S&P MidCap 400, S&P 1000, S&P Composite 1500, and S&P 400 Financials sector indices, boosting its profile among institutional investors and index-tracking funds. This index inclusion, alongside stronger investor attention to its earnings outlook and sector-wide interest in enterprise software, has sharpened the focus on how Toast’s fundamentals align with its growing role in public markets. We’ll now examine how Toast’s recent S&P...

Arlo Technologies stock has more than doubled over the past five years, yet today there is a clear split in what the valuation tools are saying. The Discounted Cash Flow (DCF) intrinsic value points to meaningful upside, while market multiples suggest the shares already trade at a premium. A roughly 111.1% return over five years puts Arlo Technologies among the stronger performers in its peer group, which raises the bar for what counts as good value at the current price. The push into AI...

In recent months, Array Digital Infrastructure completed US$1.17 billion of spectrum license sales to Verizon and T-Mobile and, following these transactions, declared an US$11 special dividend. This combination of asset sales, cash return to shareholders and subsequent analyst downgrades has sharpened investor focus on Array’s underlying organic revenue profile and evolving business direction. Next, we’ll examine how the spectrum sales and ensuing US$11 dividend reshape Array Digital...

Intercontinental Exchange (ICE) stock is back in focus after the company and NATIVX outlined plans for GPU compute futures contracts tied to the COIL Index, linking tokenized compute pricing with ICE’s existing energy markets. See our latest analysis for Intercontinental Exchange. Despite the latest GPU compute futures announcement and a series of new product launches in economic indicators and environmental markets, Intercontinental Exchange’s recent trading has been weak, with the share...

CRISPR Therapeutics (CRSP) is drawing fresh attention after being added to multiple Russell growth benchmarks, including the Russell 2000, 2500, 3000, Small Cap Comp Growth and 3000E Growth indexes. See our latest analysis for CRISPR Therapeutics. The index additions come after a period of steady momentum for CRISPR Therapeutics, with a 90-day share price return of 12.34% and a 1-year total shareholder return of 7.64%. However, the 5-year total shareholder return is down 60.91%. If the CRISPR...

Why Mirum Pharmaceuticals Stock Is Back in Focus Mirum Pharmaceuticals (MIRM) is in the spotlight after its shares rallied 5.5% following positive pivotal phase II data and an FDA priority review for rare disease drug candidate zilurgisertib. The stock has also logged a 9 day winning streak and a 25% move, lifting Mirum Pharmaceuticals market value to about US$7.3b, which may encourage investors to reassess what is already reflected in the current price. See our latest analysis for Mirum...

In late June 2026, Monster Beverage Corporation was added to multiple Russell value and defensive indexes, following earlier first-quarter 2026 results that exceeded earnings and revenue expectations and the authorization of a US$500.00 million stock repurchase program. This combination of stronger-than-expected financial performance, index inclusions, and a fresh buyback authorization highlights Monster’s growing relevance in value-oriented portfolios and institutional positioning. Next,...

NANO Nuclear Energy has recently been removed from several Russell growth and small-cap benchmarks, while also reporting leadership changes in its reactor development team and progress in the U.S. Nuclear Regulatory Commission’s review of the KRONOS microreactor construction permit at the University of Illinois Urbana-Champaign. At the same time, early-stage discussions around potential investment from a UAE-linked firm and a new Abu Dhabi memorandum of understanding highlight growing...

United Rentals (NYSE:URI) has been added to several major Russell growth indexes, including the Russell 1000 Growth, 3000 Growth, 3000E Growth, and Midcap Growth benchmarks. These index inclusions are recent and reflect changes in how United Rentals is classified across key growth-oriented benchmarks that many institutional and passive funds track. United Rentals enters this index reshuffle with a share price of $1,111.76 and a record of recent returns of 2.6% over the past week, 11.4% over...

Recent commentary around Colgate-Palmolive (CL) centers on management’s 2030 plan, as investors weigh how premium product expansion and tighter digital plus in store integration might support the stock’s appeal after several years of organic sales growth. See our latest analysis for Colgate-Palmolive. Colgate-Palmolive’s recent 1-month share price return of 4.9% and year-to-date share price return of 19.4%, with the stock now at $92.76, suggest investors are increasingly pricing in the 2030...

Over the last 7 days, the United States market has risen by 1.6%, contributing to a 21% increase over the past year, with earnings projected to grow by 19% annually. In this environment of robust growth, identifying stocks that are potentially undervalued can offer investors opportunities to capitalize on discrepancies between market price and intrinsic value estimates.

Over the last 7 days, the United States market has risen 1.6%, and in the past year, it has climbed 21%, with earnings forecasted to grow by 19% annually. In light of these positive trends, identifying stocks that combine financial robustness with growth potential is crucial for investors looking to capitalize on current conditions. Penny stocks, though often seen as a relic from earlier trading days, can still offer significant opportunities when supported by strong fundamentals; we'll...

Over the last 7 days, the United States market has risen by 1.6%, contributing to a substantial 21% increase over the past year, with earnings forecasted to grow by 19% annually. In this environment of robust growth, stocks with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the company's operations and future prospects.

Over the last 7 days, the United States market has risen by 1.6% and is up 21% over the past year with earnings forecasted to grow by 19% annually. In this favorable environment, selecting dividend stocks like Autoliv that offer consistent income and potential for growth can enhance your portfolio's stability and returns.

In late June 2026, Harley-Davidson, Inc. was reclassified across multiple FTSE Russell indices, moving from the Russell 1000 and Midcap families into the Russell 2000, including value and defensive variants, while also announcing the departure of Chief Legal, Compliance and Corporate Affairs Officer Paul Krause and the appointment of successor Gayle Littleton. This reshuffling alters which index-tracking funds hold Harley-Davidson and may influence how investors view the company’s size...

McKesson (MCK) stock has been in focus after a recent 2.09% decline, as investors weighed softer quarterly results against index additions, expanded partnerships and the company’s continued tilt toward higher margin healthcare segments. See our latest analysis for McKesson. Over the past year, McKesson’s share price return has been mixed. A recent 4.52% one-month gain contrasts with a 13.14% decline over three months and a 6.73% fall year to date. Total shareholder return over 1, 3 and 5...

In recent days, EVERTEC has attracted renewed attention as one of Latin America's leading payment processors, with analysts highlighting its strong cash generation, solid annual revenue growth and earnings expansion outpacing peers, underpinned by its ATH debit network across Latin America and the Caribbean. An important angle for investors is EVERTEC's high return on equity, which points to effective capital allocation and management discipline in scaling its payments infrastructure across...

In recent days, Digital Turbine announced the sale of select AdColony assets to Affle MEA FZ and introduced Launchpad, a unified app distribution platform aimed at simplifying deployments across carriers and device makers. Together, the asset sale and Launchpad rollout signal a sharper focus on core media and distribution capabilities, potentially streamlining Digital Turbine’s technology stack and clarifying how it creates value for app developers and partners. We’ll now examine how...

In June 2026, NeoGenomics, Inc. announced it had appointed Carolyn Starrett, former Flatiron Health CEO and experienced healthcare data and AI leader, to its Board of Directors. Her background in applying AI and real-world data to cancer care and drug development could meaningfully influence how NeoGenomics develops and commercializes its oncology testing and digital solutions. We’ll now examine how Starrett’s AI and data-driven oncology expertise may influence NeoGenomics’ existing...

Aramark (ARMK) has drawn fresh attention after being added to the Russell 1000 Defensive and Russell 1000 Value Defensive indices, a move that reflects institutional interest in the stock. See our latest analysis for Aramark. Those index additions come after a strong run in Aramark’s share price, with a 90 day share price return of 31.84% and year to date share price return of 53.36%, alongside a 5 year total shareholder return of 129.43%. This suggests momentum has been firm over both short...

BeOne Medicines recently reported positive topline Phase 3 MANGROVE results showing its BTK inhibitor BRUKINSA plus rituximab improved progression-free survival over bendamustine plus rituximab in previously untreated mantle cell lymphoma, using a chemotherapy-free, rituximab maintenance-free regimen. This is the first global Phase 3 trial to test a fully chemotherapy-free BTK inhibitor regimen as initial treatment in mantle cell lymphoma, potentially sparing patients around two years of...